{"id":39077,"date":"2025-08-12T12:03:05","date_gmt":"2025-08-12T04:03:05","guid":{"rendered":"https:\/\/flcube.com\/?p=39077"},"modified":"2025-08-12T12:03:06","modified_gmt":"2025-08-12T04:03:06","slug":"shanghai-moyang-biotechnology-secures-hundreds-of-millions-in-funding-to-expand-global-reach","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=39077","title":{"rendered":"Shanghai Moyang Biotechnology Secures Hundreds of Millions in Funding to Expand Global Reach"},"content":{"rendered":"\n

Shanghai Moyang Biotechnology Co., Ltd. announced on August 8, 2025, that it has successfully closed a new round of funding, raising several hundred million yuan. The investment was led by a major domestic venture capital firm and saw participation from renowned institutional investors, including Heda Capital and BlueRun Ventures.<\/p>\n\n\n\n

Funding Allocation<\/strong>
The newly secured capital will be primarily allocated to expanding the company’s marketing team, enhancing its global market reach, and accelerating the development of next-generation products. This strategic allocation aims to solidify Moyang Bio’s position and industrialization in the regenerative aesthetics sector.<\/p>\n\n\n\n

Company Background<\/strong>
Founded in 2018, Moyang Bio is the creator of aphranel, a premium injectable calcium hydroxylapatite (CaHA) microsphere facial filler. It holds the distinction of being the first domestically developed product of its kind to receive NMPA Class III medical device registration for aesthetic applications in China.<\/p>\n\n\n\n

Future Plans<\/strong>
With this new funding, Moyang Bio plans to fast-track the global commercial rollout of its core products, including the aphranel magic CC needle. The company is positioned to increase its market penetration in the regenerative aesthetics field and more efficiently advance its next-generation product pipeline. This will further strengthen its global leadership in the precise control technology of CaHA materials.-Fineline Info & Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Shanghai Moyang Biotechnology Co., Ltd. announced on August 8, 2025, that it has successfully closed…<\/p>\n","protected":false},"author":1,"featured_media":39078,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[1],"tags":[3785],"class_list":["post-39077","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","tag-moyang-biotechnology"],"yoast_head":"\nShanghai Moyang Biotechnology Secures Hundreds of Millions in Funding to Expand Global Reach - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Shanghai Moyang Biotechnology Co., Ltd. announced on August 8, 2025, that it has successfully closed a new round of funding, raising several hundred million yuan. The investment was led by a major domestic venture capital firm and saw participation from renowned institutional investors, including Heda Capital and BlueRun Ventures.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=39077\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Shanghai Moyang Biotechnology Secures Hundreds of Millions in Funding to Expand Global Reach\" \/>\n<meta property=\"og:description\" content=\"Shanghai Moyang Biotechnology Co., Ltd. announced on August 8, 2025, that it has successfully closed a new round of funding, raising several hundred million yuan. The investment was led by a major domestic venture capital firm and saw participation from renowned institutional investors, including Heda Capital and BlueRun Ventures.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=39077\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-12T04:03:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-12T04:03:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/1208.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=39077#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=39077\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Shanghai Moyang Biotechnology Secures Hundreds of Millions in Funding to Expand Global Reach\",\"datePublished\":\"2025-08-12T04:03:05+00:00\",\"dateModified\":\"2025-08-12T04:03:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=39077\"},\"wordCount\":219,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=39077#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/1208.webp\",\"keywords\":[\"Moyang Biotechnology\"],\"articleSection\":[\"Others\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=39077#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=39077\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=39077\",\"name\":\"Shanghai Moyang Biotechnology Secures Hundreds of Millions in Funding to Expand Global Reach - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=39077#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=39077#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/1208.webp\",\"datePublished\":\"2025-08-12T04:03:05+00:00\",\"dateModified\":\"2025-08-12T04:03:06+00:00\",\"description\":\"Shanghai Moyang Biotechnology Co., Ltd. announced on August 8, 2025, that it has successfully closed a new round of funding, raising several hundred million yuan. The investment was led by a major domestic venture capital firm and saw participation from renowned institutional investors, including Heda Capital and BlueRun Ventures.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=39077#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=39077\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=39077#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/1208.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/1208.webp\",\"width\":1080,\"height\":608,\"caption\":\"Shanghai Moyang Biotechnology Secures Hundreds of Millions in Funding to Expand Global Reach\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=39077#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shanghai Moyang Biotechnology Secures Hundreds of Millions in Funding to Expand Global Reach\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Shanghai Moyang Biotechnology Secures Hundreds of Millions in Funding to Expand Global Reach - Insight, China's Pharmaceutical Industry","description":"Shanghai Moyang Biotechnology Co., Ltd. announced on August 8, 2025, that it has successfully closed a new round of funding, raising several hundred million yuan. The investment was led by a major domestic venture capital firm and saw participation from renowned institutional investors, including Heda Capital and BlueRun Ventures.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=39077","og_locale":"en_US","og_type":"article","og_title":"Shanghai Moyang Biotechnology Secures Hundreds of Millions in Funding to Expand Global Reach","og_description":"Shanghai Moyang Biotechnology Co., Ltd. announced on August 8, 2025, that it has successfully closed a new round of funding, raising several hundred million yuan. The investment was led by a major domestic venture capital firm and saw participation from renowned institutional investors, including Heda Capital and BlueRun Ventures.","og_url":"https:\/\/flcube.com\/?p=39077","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-08-12T04:03:05+00:00","article_modified_time":"2025-08-12T04:03:06+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/1208.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=39077#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=39077"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Shanghai Moyang Biotechnology Secures Hundreds of Millions in Funding to Expand Global Reach","datePublished":"2025-08-12T04:03:05+00:00","dateModified":"2025-08-12T04:03:06+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=39077"},"wordCount":219,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=39077#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/1208.webp","keywords":["Moyang Biotechnology"],"articleSection":["Others"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=39077#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=39077","url":"https:\/\/flcube.com\/?p=39077","name":"Shanghai Moyang Biotechnology Secures Hundreds of Millions in Funding to Expand Global Reach - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=39077#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=39077#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/1208.webp","datePublished":"2025-08-12T04:03:05+00:00","dateModified":"2025-08-12T04:03:06+00:00","description":"Shanghai Moyang Biotechnology Co., Ltd. announced on August 8, 2025, that it has successfully closed a new round of funding, raising several hundred million yuan. The investment was led by a major domestic venture capital firm and saw participation from renowned institutional investors, including Heda Capital and BlueRun Ventures.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=39077#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=39077"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=39077#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/1208.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/1208.webp","width":1080,"height":608,"caption":"Shanghai Moyang Biotechnology Secures Hundreds of Millions in Funding to Expand Global Reach"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=39077#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Shanghai Moyang Biotechnology Secures Hundreds of Millions in Funding to Expand Global Reach"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/1208.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/39077","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=39077"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/39077\/revisions"}],"predecessor-version":[{"id":39079,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/39077\/revisions\/39079"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/39078"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=39077"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=39077"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=39077"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}